MTOR and hepatocellular carcinoma: Under hypoxic conditions, the mTOR pathway activation, as well as lipid accumulation and upregulated hypoxia-inducible transcription factor (HIF)-2α, have been observed in NALFD-HCC patients, correlating with a poor overall survival [80].